IFEANYI OHIAERI: Open Payments
NPI 1649892886 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$917 in 12 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $84 · 2025 $917
Food & beverage: $805Education: $111
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 5 | $387 |
| Teva Pharmaceuticals USA, Inc. | 4 | $266 |
| E.R. Squibb & Sons, L.L.C. | 1 | $122 |
| Axsome Therapeutics, Inc. | 1 | $120 |
| Alkermes, Inc. | 1 | $21 |
Products named: INGREZZA, UZEDY, COBENFY, Auvelity, ARISTADA, AUSTEDO XR.
Industry payments across TX — which companies pay providers there.
